Distinctly altered lipid components in hepatocellular carcinoma relate to impaired T cell-dependent antitumor immunity
Preprint
- 27 June 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Background and aims: T cells are master effectors of anti-tumor immunity in cancer. Recent studies suggest that altered lipid metabolism imposed by the tumor microenvironment constrains anti-tumor immunity. However, the tumor-associated lipid species changes that dampen T cell ability to control tumor progression are not fully understood. Here, we plan to clarify the influences of distinctly altered lipid components in hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) on T-cell function, aiming to seek lipid metabolic targets for improving T cell anti-tumor effects. Methods Tumor tissues and non-tumor liver from HCC patients were collected for RNA-sequencing, lipid profiling and T cell characterizing, followed by correlation analysis. Additionally, the effects of significantly changed lipid components on anti-tumor potential of T cells were tested by in vitro cell experiments and/or in vivo tumor inoculated model. Results Altered lipid metabolism coincides with impaired T cell response in HBV-related HCC. Characteristic lipid composition, significantly marked by accumulation of long-chain acylcarnitines (LCACs) and reduction of lysophosphatidylcholines (LPCs), are found in the tumor tissue. Notably, LCACs accumulated are associated with T cells exhaustion and deficient functionality, while LPCs correlate to anti-tumor effects of T cells. In particular, supplement of LPCs, including LPC (20:0) and LPC (22:0), directly promote the activation and IFN-γ secretion of T cells in vitro, and suppress tumor growth in vivo. Conclusions Our study highlights the distinctly changed lipid components closely related to T cell dysregulation in HCC, and suggests a promising strategy by decreasing LCACs and increasing LPCs for anti-tumor immunotherapy.Keywords
All Related Versions
- Version 1, 2023-06-27, Research Square
- Published version: Hepatology International, 18 (2), 582.
This publication has 27 references indexed in Scilit:
- Towards personalized, tumour-specific, therapeutic vaccines for cancerNature Reviews Immunology, 2017
- Tumor microenvironment changes leading to resistance of immune checkpoint inhibitors in metastatic melanoma and strategies to overcome resistancePharmacological Research, 2017
- Acylcarnitines: potential implications for skeletal muscle insulin resistanceThe FASEB Journal, 2014
- Endoplasmic reticulum calcium release through ITPR2 channels leads to mitochondrial calcium accumulation and senescenceNature Communications, 2014
- Influence of tumour micro-environment heterogeneity on therapeutic responseNature, 2013
- Lysophosphatidylcholine acyltransferase 1 altered phospholipid composition and regulated hepatoma progressionJournal of Hepatology, 2013
- T cell exhaustionNature Immunology, 2011
- Free fatty acid release from human breast cancer tissue inhibits cytotoxic T-lymphocyte-mediated killingJournal of Lipid Research, 2005
- Therapeutic effects of lysophosphatidylcholine in experimental sepsisNature Medicine, 2004
- Enhanced expression of group II phospholipase A2 in human hepatocellular carcinomaBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1994